| MCBVX | VEVYX | MCBVX / VEVYX | |
| Total Expense Ratio | 1.72 | 0.66 | 261% |
| Annual Report Gross Expense Ratio | 1.73 | 0.66 | 262% |
| Fund Existence | 25 years | 13 years | - |
| Gain YTD | 12.669 | 14.165 | 89% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 17.2B | 15.3B | 112% |
| Annual Yield % from dividends | 0.05 | 1.11 | 5% |
| Returns for 1 year | 8.16 | 10.65 | 77% |
| Returns for 3 years | 16.05 | 13.06 | 123% |
| Returns for 5 years | 12.39 | 10.07 | 123% |
| Returns for 10 years | 67.88 | 68.40 | 99% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| KMKNX | 83.69 | N/A | N/A |
| Kinetics Market Opportunities No Load | |||
| LCLIX | 43.65 | N/A | N/A |
| ClearBridge Large Cap Value 1 | |||
| LICVX | 21.53 | N/A | N/A |
| Lord Abbett International Equity R6 | |||
| LYFCX | 18.17 | N/A | N/A |
| AlphaCentric Life Sciences & Hlthcare C | |||
| VWICX | 19.24 | N/A | N/A |
| Vanguard International Core Stock Inv | |||